Antianxiety and Antidepressant Effects from a Single Dose of Psychedelic Drug Persist Years Later in Cancer Patients

Following up on their landmark 2016 study, researchers at NYU Grossman School of Medicine found that a one-time, single-dose treatment of psilocybin, a compound found in psychedelic mushrooms, combined with psychotherapy appears to be associated with significant improvements in emotional and existential distress in cancer patients.

Read more

Zimmerli Art Museum Offers New Tools for Visitors with Sensory-Related Disorders

The Zimmerli Art Museum at Rutgers University-New Brunswick is the first art museum in New Jersey to offer specialized tools to help visitors in the autism spectrum enjoy their visit without stressful sensory overload.

Read more

With Novel Technique, New Study Is First to Definitively Map the Early Development of PTSD

Only 23% of people who experience trauma develop PTSD. New research offers clues on identifying which trauma victims will develop the disorder and suggests potential interventions. Findings are based on a novel technique that gathered patient information in the critical 30 days following the trauma.

Read more

Depression, anxiety may hinder healing in young patients with hip pain

Researchers at Washington University School of Medicine in St. Louis have found that depression and anxiety in patients with hip pain are associated with worse outcomes following hip surgery, including more postsurgical pain, slower recovery and inadequate return to activity.

Read more